Adverse effects of DMARDs in treatment of rheumatoid arthritis
Sugii, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 1): 566-572
2005
ISSN/ISBN: 0047-1852 PMID: 15799419 Document Number: 587346
Document emailed within 1 workday
Related Documents
Menon, N.; Kothari, S.Y.; Gogna, A.; Sharma, R. 2014: Comparison of intra-articular glucocorticoid injections with DMARDs versus DMARDs alone in rheumatoid arthritis Journal of the Association of Physicians of India 62(8): 673-676Suzuki, Y.; Saito, E.; Wakabayashi, T.; Suwa, A. 2007: Adverse effects of conventional DMARDs and biologic DMARDs Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl. 8: 209-217
Wacharapornin, P.; Suwannalai, P. 2014: Predictors for low disease activity and remission in rheumatoid arthritis patients treated with biological DMARDs Journal of the Medical Association of Thailand 97(11): 1157-1163
Vázquez, I.; Graell, E.; Gratacós, J.; Cañete, J.D.; Viñas, O.; Ercilla, M.G.; Gómez, A.; Hernández, M.V.; Rodríguez-Cros, J.R.; Larrosa, M.; Sanmartí, R. 2007: Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting Clinical and experimental rheumatology 25(2): 231-238
Narvaez, J.; Díaz-Torné, C.; Ruiz, J.M.; Hernandez, M.V.; Torrente-Segarra, V.; Ros, S.; Rodriguez de la Serna, A.; Díaz-López, C.; Sanmartí, R.; Nolla, J.M. 2011: Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDs Clinical and Experimental Rheumatology 29(6): 991-997
Amann, J.; Wessels, A-Marie.; Breitenfeldt, F.; Huscher, Dörte.; Bijlsma, J.W.J.; Jacobs, J.W.G.; Buttgereit, F. 2017: Quantifying cutaneous adverse effects of systemic glucocorticoids in patients with rheumatoid arthritis: a cross-sectional cohort study Clinical and Experimental Rheumatology 35(3): 471-476
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Petersen, J.; Halberg, P.; Hansen, T.M. 1979: Side effects in the treatment of rheumatoid arthritis with levamisole (Decaris) Ugeskrift for Laeger 141(31): 2123-2125
Mielants, H.; Veys, E.M. 1979: Hematologic side effects of levamisole in the treatment of rheumatoid arthritis Acta Rhumatologica 3(3): 231-240
Marica Marković; Majki, N.ć-Singh; Ignjatovi, S.ć 2009: Beneficial Effects of Cellular Stress Response in Traditional Spa Treatment of Rheumatoid Arthritis Clinical Laboratory 55(5-6): 235-241
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Kiortsis, D.N.; Mavridis, A.K.; Filippatos, T.D.; Vasakos, S.; Nikas, S.N.; Drosos, A.A. 2006: Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis Journal of Rheumatology 33(5): 921-923
Marbet, U.A.; Graf, U.; Mihatsch, M.J.; Gratwohl, A.; Müller, W.; Thiel, G. 1980: Renal side effects of treatment with cyclosporin A in rheumatoid arthritis and after bone marrow transplantation Schweizerische Medizinische Wochenschrift 110(52): 2017-2020
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Jiang, L.; Zhao, N.; Ni, L. 2002: Retrospective study of adverse events in patients with rheumatoid arthritis treated with second-line drugs Zhonghua Liu Xing Bing Xue Za Zhi 23(3): 213-217
Furst, D.E.; Erikson, N.; Clute, L.; Koehnke, R.; Burmeister, L.F.; Kohler, J.A. 1990: Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis Journal of Rheumatology 17(12): 1628-1635
Alekseev, E.I.; Shakhbazian, I.E.; Ulybina, O.V.; Khudoleeva, E.I. 2001: Effectiveness and side-effects of long-term treatment with glucocorticoids in patients with juvenile rheumatoid arthritis Klinicheskaia Meditsina 79(3): 33-38
Sund, S.; Førre, O.; Berg, K.J.; Kvien, T.K.; Hovig, T. 1994: Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis Clinical Nephrology 41(1): 33-40
Kitamura, A. 1994: Study of the effects of a new vitamin D3 derivative on type Ii collagen-induced arthritis in an experimental rat model of rheumatoid arthritis Nihon Seikeigeka Gakkai Zasshi 68(12): 1068-1080